A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.

The Three Volcanoes Park LLC  will build a world-class tourism cluster in the area of Vilyuchinsky, Mutnovsky and Gorely volcanoes, with access to Vilyuchinsky Bay.

Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.

The common take-away was that «to become nature lovers, people need to have access to nature». Thus, the number one task is to create a legislative framework, currently all but non-existent.